Talk to your doctor about how morning blood sugar (FPG), after-meal blood sugar
(PPG), or both, can affect your A1C level.
Your doctor may recommend that you
measure your blood sugar in the morning
and after meals using a meter. The reading
you take in the morning before you eat is called
your FPG or fasting number. This reading will
help you and your doctor better understand how
well your blood sugar is being controlled when
you haven't eaten in a while.
Another important reading to take is your PPG
or after-meal number. Everyone's blood
sugar spikes after they eat. But if you have type 2 diabetes, it may spike too high,
a signal that you need more control.
Morning blood sugar (FPG), after-meal blood sugar (PPG), or both, can affect your
A1C level.
A1C reflects a 3-month average of your blood sugar. This reading is done at your
doctor's office or at a lab. Your doctor will use the results from your A1C test
as well as your before-meal and after-meal readings to help manage your type 2 diabetes.
If your doctor thinks your after-meal or morning blood sugar or your A1C levels
are too high, your doctor may need to adjust your current treatment or add another
medication to your current oral diabetes medicine.
The American Diabetes Association recommends an A1C of under 7
Make sure you talk to your doctor about your goals for your morning blood sugar
(FPG), your after-meal blood sugar (PPG) and your A1C, and how you can best achieve
them.
Onglyza (saxagliptin) may help you achieve better blood sugar control
In clinical studies, Onglyza lowered A1C, morning blood sugar (FPG), after-meal blood sugar (PPG) when added to one of several common oral diabetes medicines:
metformin, a sulfonylurea, or a thiazolidinedione (TZD). If you have allergic (hypersensitivity) reactions, such as rash, hives, and swelling of the face, lips and throat, stop taking ONGLYZA and call
your healthcare provider right away.
When Onglyza is used with certain other diabetes medicines to treat high blood sugar,
such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is higher.
Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat,
change in mood, and change in vision. Follow your doctor’s instructions for treating low
blood sugar.
When Onglyza is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone,
to treat high blood sugar, peripheral edema (fluid retention) may become worse.
If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles,
call your doctor.